Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Zealand Pharma

301.90 DKK

+1.82 %

Less than 1K followers

ZEAL

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Zealand Pharma

2019202020212022202320242025
Revenue41.3353.3292.6104.0342.862.79,214.9
growth-%754.8 %-17.2 %-64.5 %229.6 %-81.7 %14,599.1 %
EBITDA-587.9-749.7-1,012.1-837.2-572.2-1,272.26,986.8
EBIT-587.9-792.4-1,052.4-837.2-572.2-1,272.26,959.4
Profit before taxes-576.7-839.7-1,026.9-972.0-708.9-1,083.57,001.1
Net income-571.5-846.7-1,018.1-1,202.1-703.7-1,078.86,455.0
EPS-16.91-21.28-23.75-26.02-12.44-16.2491.56
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-1,422.5 %-212.2 %-345.9 %-805.0 %-166.9 %-2,029.4 %75.8 %
EBIT-%-1,422.5 %-224.3 %-359.7 %-805.0 %-166.9 %-2,029.4 %75.5 %
ROE-46.0 %-68.9 %-109.7 %-147.3 %-44.2 %-12.5 %43.5 %
ROI-35.7 %-48.1 %-49.2 %-78.1 %-35.5 %-11.3 %40.5 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.